ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Junshi, Lilly to Co-develop Antibody Therapies for COVID-19
May 13, 2020Multiple neutralizing antibodies have been engineered, with the lead asset poised to enter clinical testing in the second quarter. -
Eli Lilly, Junshi collaborate to develop antibody therapies for Covid-19 disease
May 05, 2020Eli Lilly has collaborated with Junshi Biosciences for the development of therapeutic antibodies to treat and prevent Covid-19, the disease resulted due to the SARS-CoV-2 novel coronavirus. -
Covid-19: Junshi Biosciences, OliX Pharmaceuticals explore drugs
March 24, 2020Junshi Biosciences has partnered with the Institute of Microbiology of the Chinese Academy of Sciences (IMCAS) to co-develop neutralising antibodies for Covid-19 treatment. -
Junshi Biosciences aims for $414M Hong Kong, S.A.R., China IPO: Reuters
December 28, 2018China’s Junshi Biosciences may follow in compatriot Innovent Biologics’ footsteps as it tees up to raise $414 million in its Hong Kong, S.A.R., China IPO....
Pharma Sources Insight January 2025
